The maximum dose of cyclobenzaprine is 30 mg per day for the immediate-release tablet, taken as 10 mg three times daily. Most people start at 5 mg three times daily, with the dose increased only if needed. An extended-release version also caps at 30 mg per day but is taken as a single dose.
Immediate-Release Tablets
The standard starting dose is 5 mg taken three times a day, for a total of 15 mg daily. If that isn’t enough, your prescriber may increase each dose to 10 mg three times a day, bringing the daily total to 30 mg. That 30 mg ceiling is the FDA-labeled maximum. The three doses should be spread roughly evenly across waking hours.
Cyclobenzaprine is intended for short-term use alongside rest and physical therapy for acute muscle spasms. It is not designed for long-term pain management, and prescribers generally limit a course of treatment to two or three weeks.
Extended-Release Capsules
The extended-release form (sold as Amrix) is taken once daily instead of three times. The typical starting dose is one 15 mg capsule. If more relief is needed, the dose can go up to 30 mg once daily, either as a single 30 mg capsule or two 15 mg capsules taken together. So the daily ceiling is the same 30 mg, just delivered in one dose rather than three.
How Cyclobenzaprine Works
Cyclobenzaprine acts in the brain and spinal cord rather than directly on your muscles. It activates a cluster of neurons in the brainstem that release a chemical messenger called noradrenaline into the spinal cord. That extra noradrenaline dampens the overactive nerve signals that cause muscles to spasm. Because it works centrally, sedation and drowsiness are expected side effects, not just occasional ones.
Why the Dose Matters for Older Adults
The American Geriatrics Society lists cyclobenzaprine on its Beers Criteria, a widely used guide to medications that are risky for people over 65. The recommendation is to avoid it entirely in this age group. Older adults are more sensitive to its sedating and anticholinergic effects (dry mouth, constipation, confusion, blurred vision), and the resulting drowsiness raises the risk of falls and fractures. Even at lower doses, the drug is often poorly tolerated, and its effectiveness at doses older adults can handle is questionable.
Liver Function Changes the Equation
Cyclobenzaprine is processed by the liver, so impaired liver function slows its clearance and effectively raises the amount of drug circulating in your body. People with mild to moderate liver problems typically need a lower dose, often starting at 5 mg and staying there. The drug is not recommended at all for people with severe liver impairment.
Serotonin Syndrome Risk
Cyclobenzaprine is structurally similar to older antidepressants, and it can contribute to a dangerous condition called serotonin syndrome when combined with other medications that raise serotonin levels. The FDA label specifically flags this risk with common antidepressants (SSRIs and SNRIs), tramadol, bupropion, and several other drugs. Symptoms of serotonin syndrome include agitation, rapid heartbeat, high body temperature, muscle twitching, and confusion. The risk is highest when starting the medication or increasing the dose, especially if you already take one of these other drugs.
What Happens Above 30 mg
Exceeding the labeled maximum increases the chance of serious side effects without added benefit. In a large review of cyclobenzaprine toxicity cases, the most common effects were extreme drowsiness (reported in over half of cases) and rapid heart rate (about a third of cases). Higher overdose amounts can cause confusion, hallucinations, dangerously low blood pressure, delirium, and in severe cases, cardiac arrest or coma. Recreational misuse in the 20 to 80 mg range has been documented to cause heavy sedation and euphoria, but also carries significant cardiovascular risk. At very high concentrations, the drug can cause irreversible depression of heart function.
If you suspect someone has taken more than the prescribed amount, that warrants emergency medical attention regardless of whether symptoms have appeared yet.